Background Psoriasis is an immune‐mediated disease with either skin or joints
manifestations, or both, and it has a major impact on quality of life. Although there is …

Psoriasis is a chronic inflammatory skin disorder, and current treatments include topical
therapies, phototherapy, systemic immune modulators, and biologics, aiming to alleviate …

Progress in understanding of the mechanisms underlying chronic inflammatory skin
disorders, such as atopic dermatitis and psoriasis vulgaris, has led to new treatment options …

Psoriasis is a chronic, autoimmune, and non-communicable skin disease with a worldwide
prevalence rate of 2–3%, creating an economic burden on global health. Some significant …

Introduction Chronic inflammatory skin diseases may have a profound negative impact on
the quality of life. Current treatment options may be inadequate, offering an unsatisfactory …

Background Brodalumab, a fully human IgG2k antibody blocking the receptor of IL17, is
characterized by a rapid onset of action with high skin clearance rates in clinical trials. Since …

Transdermal drug delivery is a promising strategy characterized by minor fluctuations in
blood concentrations, few adverse effects, convenience, and excellent patient compliance …

Axial spondyloarthritis (axSpA) encompasses radiographic axial SpA (r-axSpA), formally
designated as ankylosing spondylitis (AS) and non-radiographic axial SpA (nr-axSpA). The …

Summary Background Regulatory T cells (Tregs) can alleviate the development of
autoimmune and inflammatory diseases, thereby proposing their role as a new therapeutic …

Psoriasis (PSO) is an inflammatory skin condition that causes a variety of diseases and
significantly decreases the life characteristics of patients, and substantially diminishes …